UPDATE
: Friday, February 22, 2019
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Insurance benefit for breast cancer treatment ‘Faslodex’ put on hold
Insurance benefits for Faslodex (Ingredient: fulvestrant), AstraZeneca’s br...
by Song Soo-youn
|
2019-02-22 17:29
라인
Celltrion Healthcare posts ₩713.5 billion in 2018 sales
Celltrion Healthcare, a subsidiary of Celltrion, said Friday that it record...
by Lee Han-soo
|
2019-02-22 17:29
라인
Alteogen applies for P1 trial for Eylea biosimilar
Alteogen said Friday that it has filed an investigational new drug applicat...
by Lee Han-soo
|
2019-02-22 16:03
라인
[News Focus] Why did court acquit Ewha hospital staffs in newborns’ death case?
A Seoul court acquitted medical staffs at Ewha Womans University Hospital o...
by Choi Gwang-seok
|
2019-02-22 16:02
라인
Regulator OKs Bukwang’s anticancer treatment
Bukwang Pharmaceutical said Thursday that the Ministry of Food and Drug Saf...
by Lee Han-soo
|
2019-02-22 15:29
라인
Will first-ever treatment for nonalcoholic fatty liver arrive?
Pharmaceutical firms around the world are striving to become the world’s fi...
by Kim Yun-mi
|
2019-02-22 15:29
라인
CHA Medical Center, CG Bio to develop 3D bio-printing-based stem cell transporter
CHA Bundang Medical Center said Thursday that it has signed a business agre...
by Lee Han-soo
|
2019-02-22 14:10
라인
Hugel hits record-high quarterly sales
Hugel said Friday it registered highest quarterly turnover in the final thr...
by Lee Han-soo
|
2019-02-22 13:30
라인
Medical cannabis imports allowed only through orphan drug center
As Korea moves to allow medical marijuana imports for self-treatment purpos...
by Lee Hye-seon
|
2019-02-22 10:55
라인
Huons posts record-high sales in 2018
Huons said Wednesday that it registered 328.6 billion won ($291.9 million) ...
by Lee Han-soo
|
2019-02-21 17:17
라인
Severance Hospital transfers colorectal cancer treatment candidate to Israeli firm
Yonsei Cancer Center and the Korea Research Institute of Chemical Technolog...
by Lee Han-soo
|
2019-02-21 15:30
라인
International groups praise Korea’s dementia-combating efforts
Officials from international organizations, including the World Health Orga...
by Lee Han-soo
|
2019-02-21 15:28
라인
Mediforum verifies safety, efficacy of dementia treatment candidate
Mediforum said Thursday it has verified the safety and efficacy of PM012, a...
by Lee Han-soo
|
2019-02-21 15:13
라인
DPP-4 inhibitors raise bullous pemphigoid risk in diabetic patients: study
Inhibitors of dipeptidyl peptidase 4 (DPP-4), used to treat diabetes, can i...
by Kim Yun-mi
|
2019-02-21 15:13
라인
Xtandi adds indication for non-metastatic castration-resistant prostate cancer
Astellas Pharma Korea said it obtained regulatory approval for Xtandi (ingr...
by Kim Yun-mi
|
2019-02-21 15:10
라인
SCM, Allele to develop diabetes treatment
SCM Life Science said Thursday it has signed a joint research agreement wit...
by Lee Han-soo
|
2019-02-21 14:57
라인
Korea to revise limited exclusive sales rights approval
The Ministry of Food and Drug Safety said it was pushing to amend the limit...
by Lee Hye-seon
|
2019-02-21 11:28
라인
State research organ finds new genes expediting gastritis, gastric cancer
Researchers at Korea Research Institute of Bioscience & Biotechnology (KRIB...
by Lee Han-soo
|
2019-02-21 11:26
라인
Ewha Medical Center, LG U+ open Korea’s 1st ‘smart sleeping room’
Ewha Womans University Medical Center cooperated with LG U+ to install Kore...
by Lee Han-soo
|
2019-02-20 17:27
라인
Regulator to inspect 12 biopharmaceutical plants overseas
The Ministry of Food and Drug Safety said it would conduct a regular inspec...
by Lee Hye-seon
|
2019-02-20 16:18
-
1
2
3
4
5
6
7
8
9
10
다음
-
Insurance benefit for breast cancer treatment ‘Faslodex’ put on hold
Celltrion Healthcare posts ₩713.5 billion in 2018 sales
Alteogen applies for P1 trial for Eylea biosimilar
[News Focus] Why did court acquit Ewha hospital staffs in newborns’ death case?
Insurance benefit for breast cancer treatment ‘Faslodex’ put on hold
Celltrion Healthcare posts ₩713.5 billion in 2018 sales
Alteogen applies for P1 trial for Eylea biosimilar
[News Focus] Why did court acquit Ewha hospital staffs in newborns’ death case?
여백
Most viewed
1
‘Hair loss drug Propesia works well for Koreans in long term’
2
Pfizer’s patent barrier foils Korea’s 1st pneumococcal conjugate vaccine
3
Government to spend ₩3 trillion on innovative drugs, dementia, medical scientists
4
Ministry OKs Peptron’s P2 clinical trial of Parkinson’s disease treatment
5
State research organ finds new genes expediting gastritis, gastric cancer
6
Hanmi’s RaboneD dominates osteoporosis therapy market
7
Technoclone to supply Handok diagnostic reagent for ADAMTS-13 activity test
8
Severance Hospital transfers colorectal cancer treatment candidate to Israeli firm
9
[News Focus] Will MSD’s new antidiabetic SGLT-2 inhibitor prove effective?
10
Pharma Research Bio wins nod to export botulinum toxin
여백
Opinion
[Reporter’s Notebook] TV dramas misportray mental hospitals
[Column] Patient stabbed doctor to death -- things can’t just go on like this
[Column]Korea’s healthcare industry; do flowers blossom in desert, too?
여백
Back to Top